×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Insider Transactions by Samuel Kintz

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
ELVNEnliven Therapeutics, Inc.Samuel KintzPRESIDENT AND CEOAug 19, 2025Sale$20.0059011,800929,409Aug 20, 2025, 04:36 PM
ELVNEnliven Therapeutics, Inc.Samuel KintzPRESIDENT AND CEOAug 18, 2025Sale$20.0210,393208,106929,999Aug 20, 2025, 04:36 PM
ELVNEnliven Therapeutics, Inc.Samuel KintzPRESIDENT AND CEOJul 17, 2025Sale$22.5212,500281,518948,742Jul 21, 2025, 07:21 PM
ELVNEnliven Therapeutics, Inc.Samuel KintzPRESIDENT AND CEOJun 17, 2025Sale$22.1812,500277,292954,890Jun 18, 2025, 06:22 PM
ELVNEnliven Therapeutics, Inc.Samuel KintzPRESIDENT AND CEOJun 03, 2025Sale$20.057,500150,352965,392Jun 05, 2025, 04:53 PM
ELVNEnliven Therapeutics, Inc.Samuel KintzPRESIDENT AND CEOMay 19, 2025Sale$16.495,00082,453972,892May 21, 2025, 06:29 PM
ELVNEnliven Therapeutics, Inc.Samuel KintzPRESIDENT AND CEOMay 01, 2025Sale$20.085,330107,007980,062May 05, 2025, 06:42 PM
ELVNEnliven Therapeutics, Inc.Samuel KintzPRESIDENT AND CEOMay 02, 2025Sale$20.002,17043,409977,892May 05, 2025, 06:42 PM
ELVNEnliven Therapeutics, Inc.Samuel KintzPRESIDENT AND CEOApr 17, 2025Sale$16.425,00082,096985,392Apr 21, 2025, 05:55 PM
ELVNEnliven Therapeutics, Inc.Samuel KintzPRESIDENT AND CEOMar 17, 2025Sale$20.8312,500260,320990,392Mar 19, 2025, 05:42 PM
ELVNEnliven Therapeutics, Inc.Samuel KintzPRESIDENT AND CEOOct 18, 2024Sale$30.0092427,7231,002,892Oct 22, 2024, 04:21 PM
ELVNEnliven Therapeutics, Inc.Samuel KintzPRESIDENT AND CEOOct 08, 2024Sale$27.9613,267370,9291,020,626Oct 10, 2024, 08:38 PM
ELVNEnliven Therapeutics, Inc.Samuel KintzPRESIDENT AND CEOOct 09, 2024Sale$28.1516,710470,4051,006,646Oct 10, 2024, 08:38 PM
ELVNEnliven Therapeutics, Inc.Samuel KintzPRESIDENT AND CEOOct 04, 2024Sale$27.5112,206335,7921,036,523Oct 08, 2024, 06:57 PM
ELVNEnliven Therapeutics, Inc.Samuel KintzPRESIDENT AND CEOOct 07, 2024Sale$27.502,73075,0751,033,793Oct 08, 2024, 06:57 PM
ELVNEnliven Therapeutics, Inc.Samuel KintzPRESIDENT AND CEOOct 01, 2024Sale$27.5452614,4851,048,729Oct 03, 2024, 06:45 PM
ELVNEnliven Therapeutics, Inc.Samuel KintzPRESIDENT AND CEOAug 26, 2024Sale$22.8912,000274,7181,049,255Aug 28, 2024, 07:48 PM
ELVNEnliven Therapeutics, Inc.Samuel KintzPRESIDENT AND CEOJul 31, 2024Sale$27.562,27062,5551,061,255Aug 02, 2024, 07:25 PM
ELVNEnliven Therapeutics, Inc.Samuel KintzPRESIDENT AND CEOJul 25, 2024Sale$24.9212,000299,0731,071,732Jul 29, 2024, 05:39 PM
ELVNEnliven Therapeutics, Inc.Samuel KintzPRESIDENT AND CEOJun 25, 2024Sale$21.6612,000259,9021,076,103Jun 27, 2024, 04:35 PM
ELVNEnliven Therapeutics, Inc.Samuel KintzPRESIDENT AND CEOMay 28, 2024Option/RSU Exercise$1.1212,00013,44012,000May 30, 2024, 05:56 PM
ELVNEnliven Therapeutics, Inc.Samuel KintzPRESIDENT AND CEOMay 28, 2024Sale$23.1812,000278,2105,319May 30, 2024, 05:56 PM
ELVNEnliven Therapeutics, Inc.Samuel KintzPRESIDENT AND CEOApr 25, 2024Option/RSU Exercise$1.1212,00013,44012,000Apr 29, 2024, 06:50 PM
ELVNEnliven Therapeutics, Inc.Samuel KintzPRESIDENT AND CEOApr 25, 2024Sale$16.8912,000202,7000Apr 29, 2024, 06:50 PM
ELVNEnliven Therapeutics, Inc.Samuel KintzPRESIDENT AND CEOApr 11, 2024Option/RSU Exercise$1.1247,70953,43447,709Apr 15, 2024, 07:05 PM
ELVNEnliven Therapeutics, Inc.Samuel KintzPRESIDENT AND CEOApr 11, 2024Sale$25.0447,7091,194,7000Apr 15, 2024, 07:05 PM
ELVNEnliven Therapeutics, Inc.Samuel KintzPRESIDENT AND CEOMar 25, 2024Sale$17.5612,000210,6614,671Mar 27, 2024, 05:03 PM
ELVNEnliven Therapeutics, Inc.Samuel KintzPRESIDENT AND CEOMar 25, 2024Option/RSU Exercise$1.1212,00013,44012,000Mar 27, 2024, 05:03 PM
ELVNEnliven Therapeutics, Inc.Samuel KintzPRESIDENT AND CEOFeb 26, 2024Option/RSU Exercise$1.1212,00013,44012,000Feb 28, 2024, 05:14 PM
ELVNEnliven Therapeutics, Inc.Samuel KintzPRESIDENT AND CEOFeb 26, 2024Sale$16.8912,000202,6534,376Feb 28, 2024, 05:14 PM
ELVNEnliven Therapeutics, Inc.Samuel KintzPresident and CEOJan 25, 2024Option/RSU Exercise$1.1212,00013,44012,000Jan 29, 2024, 08:01 PM
ELVNEnliven Therapeutics, Inc.Samuel KintzPresident and CEOJan 25, 2024Sale$15.6912,000188,2299,458Jan 29, 2024, 08:01 PM
ELVNEnliven Therapeutics, Inc.Samuel KintzPresident and CEODec 26, 2023Sale$14.6412,000175,7090Dec 28, 2023, 04:29 PM
ELVNEnliven Therapeutics, Inc.Samuel KintzPresident and CEODec 26, 2023Option/RSU Exercise$1.1212,00013,44012,000Dec 28, 2023, 04:29 PM
ELVNEnliven Therapeutics, Inc.Samuel KintzPresident and CEODec 21, 2023Option/RSU Exercise$1.12202220Dec 26, 2023, 07:31 PM
ELVNEnliven Therapeutics, Inc.Samuel KintzPresident and CEODec 21, 2023Sale$13.00202600Dec 26, 2023, 07:31 PM
ELVNEnliven Therapeutics, Inc.Samuel KintzPresident and CEODec 22, 2023Option/RSU Exercise$1.128,1759,1568,175Dec 26, 2023, 07:31 PM
ELVNEnliven Therapeutics, Inc.Samuel KintzPresident and CEODec 22, 2023Sale$13.058,175106,6550Dec 26, 2023, 07:31 PM
ELVNEnliven Therapeutics, Inc.Samuel KintzPresident and CEODec 20, 2023Option/RSU Exercise$1.127,7798,7127,779Dec 21, 2023, 04:31 PM
ELVNEnliven Therapeutics, Inc.Samuel KintzPresident and CEODec 20, 2023Sale$13.017,779101,2380Dec 21, 2023, 04:31 PM
ELVNEnliven Therapeutics, Inc.Samuel KintzPresident and CEONov 03, 2023Option/RSU Exercise$1.128,0268,9898,026Nov 06, 2023, 04:42 PM
ELVNEnliven Therapeutics, Inc.Samuel KintzPresident and CEONov 03, 2023Sale$13.088,026104,9990Nov 06, 2023, 04:42 PM
ELVNEnliven Therapeutics, Inc.Samuel KintzPresident and CEOSep 25, 2023Sale$13.8112,000165,6910Sep 26, 2023, 07:37 PM
ELVNEnliven Therapeutics, Inc.Samuel KintzPresident and CEOSep 25, 2023Option/RSU Exercise$1.1212,00013,44012,000Sep 26, 2023, 07:37 PM